Chapter/Section Purchase

1 Study Coverage
1.1 Nucleic Acid Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Nucleic Acid Vaccine Market Size Growth Rate by Type
1.2.2 Preventive Nucleic Acid Vaccine
1.2.3 Therapeutic Vucleic Acid Vaccine
1.3 Market by Application
1.3.1 Global Nucleic Acid Vaccine Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Nucleic Acid Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Nucleic Acid Vaccine Revenue 2016-2027
2.1.2 Global Nucleic Acid Vaccine Sales 2016-2027
2.2 Global Nucleic Acid Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Nucleic Acid Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Nucleic Acid Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Nucleic Acid Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Nucleic Acid Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Nucleic Acid Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Nucleic Acid Vaccine Revenue Forecast by Region (2022-2027)

3 Global Nucleic Acid Vaccine Competitor Landscape by Players
3.1 Global Top Nucleic Acid Vaccine Manufacturers by Sales
3.1.1 Global Nucleic Acid Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Nucleic Acid Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Nucleic Acid Vaccine Manufacturers by Revenue
3.2.1 Key Nucleic Acid Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Nucleic Acid Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Nucleic Acid Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Nucleic Acid Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Nucleic Acid Vaccine Revenue in 2020
3.2.6 Global Nucleic Acid Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Nucleic Acid Vaccine Price by Manufacturers
3.4 Global Nucleic Acid Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Nucleic Acid Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nucleic Acid Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Nucleic Acid Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Nucleic Acid Vaccine Market Size by Type (2016-2021)
4.1.1 Global Nucleic Acid Vaccine Sales by Type (2016-2021)
4.1.2 Global Nucleic Acid Vaccine Revenue by Type (2016-2021)
4.1.3 Nucleic Acid Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Nucleic Acid Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Nucleic Acid Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Nucleic Acid Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Nucleic Acid Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Nucleic Acid Vaccine Market Size by Application (2016-2021)
5.1.1 Global Nucleic Acid Vaccine Sales by Application (2016-2021)
5.1.2 Global Nucleic Acid Vaccine Revenue by Application (2016-2021)
5.1.3 Nucleic Acid Vaccine Price by Application (2016-2021)
5.2 Nucleic Acid Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Nucleic Acid Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Nucleic Acid Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Nucleic Acid Vaccine Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Nucleic Acid Vaccine Market Size YoY Growth 2016-2027
6.1.1 China Nucleic Acid Vaccine Sales YoY Growth 2016-2027
6.1.2 China Nucleic Acid Vaccine Revenue YoY Growth 2016-2027
6.1.3 China Nucleic Acid Vaccine Market Share in Global Market 2016-2027
6.2 China Nucleic Acid Vaccine Market Size by Players (International and Local Players)
6.2.1 China Top Nucleic Acid Vaccine Players by Sales (2016-2021)
6.2.2 China Top Nucleic Acid Vaccine Players by Revenue (2016-2021)
6.3 China Nucleic Acid Vaccine Historic Market Review by Type (2016-2021)
6.3.1 China Nucleic Acid Vaccine Sales Market Share by Type (2016-2021)
6.3.2 China Nucleic Acid Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 China Nucleic Acid Vaccine Price by Type (2016-2021)
6.4 China Nucleic Acid Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Nucleic Acid Vaccine Sales Forecast by Type (2022-2027)
6.4.2 China Nucleic Acid Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 China Nucleic Acid Vaccine Price Forecast by Type (2022-2027)
6.5 China Nucleic Acid Vaccine Historic Market Review by Application (2016-2021)
6.5.1 China Nucleic Acid Vaccine Sales Market Share by Application (2016-2021)
6.5.2 China Nucleic Acid Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 China Nucleic Acid Vaccine Price by Application (2016-2021)
6.6 China Nucleic Acid Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Nucleic Acid Vaccine Sales Forecast by Application (2022-2027)
6.6.2 China Nucleic Acid Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 China Nucleic Acid Vaccine Price Forecast by Application (2022-2027)

7 North America
7.1 North America Nucleic Acid Vaccine Market Size YoY Growth 2016-2027
7.2 North America Nucleic Acid Vaccine Market Facts & Figures by Country
7.2.1 North America Nucleic Acid Vaccine Sales by Country (2016-2021)
7.2.2 North America Nucleic Acid Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Nucleic Acid Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Nucleic Acid Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Nucleic Acid Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Nucleic Acid Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Nucleic Acid Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Nucleic Acid Vaccine Market Facts & Figures by Country
9.2.1 Europe Nucleic Acid Vaccine Sales by Country (2016-2021)
9.2.2 Europe Nucleic Acid Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Nucleic Acid Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Nucleic Acid Vaccine Market Facts & Figures by Country
10.2.1 Latin America Nucleic Acid Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Nucleic Acid Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Nucleic Acid Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Nucleic Acid Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Nucleic Acid Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Nucleic Acid Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Moderna
12.1.1 Moderna Corporation Information
12.1.2 Moderna Description and Business Overview
12.1.3 Moderna Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Moderna Nucleic Acid Vaccine Products Offered
12.1.5 Moderna Recent Development
12.2 CureVac
12.2.1 CureVac Corporation Information
12.2.2 CureVac Description and Business Overview
12.2.3 CureVac Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CureVac Nucleic Acid Vaccine Products Offered
12.2.5 CureVac Recent Development
12.3 Inovio
12.3.1 Inovio Corporation Information
12.3.2 Inovio Description and Business Overview
12.3.3 Inovio Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Inovio Nucleic Acid Vaccine Products Offered
12.3.5 Inovio Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Description and Business Overview
12.4.3 Sanofi Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi Nucleic Acid Vaccine Products Offered
12.4.5 Sanofi Recent Development
12.5 GSK
12.5.1 GSK Corporation Information
12.5.2 GSK Description and Business Overview
12.5.3 GSK Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GSK Nucleic Acid Vaccine Products Offered
12.5.5 GSK Recent Development
12.6 CNBG
12.6.1 CNBG Corporation Information
12.6.2 CNBG Description and Business Overview
12.6.3 CNBG Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 CNBG Nucleic Acid Vaccine Products Offered
12.6.5 CNBG Recent Development
12.7 Hualan Bio
12.7.1 Hualan Bio Corporation Information
12.7.2 Hualan Bio Description and Business Overview
12.7.3 Hualan Bio Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hualan Bio Nucleic Acid Vaccine Products Offered
12.7.5 Hualan Bio Recent Development
12.8 Zhifei Shengwu
12.8.1 Zhifei Shengwu Corporation Information
12.8.2 Zhifei Shengwu Description and Business Overview
12.8.3 Zhifei Shengwu Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Zhifei Shengwu Nucleic Acid Vaccine Products Offered
12.8.5 Zhifei Shengwu Recent Development
12.9 Liaoning Chengda
12.9.1 Liaoning Chengda Corporation Information
12.9.2 Liaoning Chengda Description and Business Overview
12.9.3 Liaoning Chengda Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Liaoning Chengda Nucleic Acid Vaccine Products Offered
12.9.5 Liaoning Chengda Recent Development
12.10 BioKangtai
12.10.1 BioKangtai Corporation Information
12.10.2 BioKangtai Description and Business Overview
12.10.3 BioKangtai Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 BioKangtai Nucleic Acid Vaccine Products Offered
12.10.5 BioKangtai Recent Development
12.11 Moderna
12.11.1 Moderna Corporation Information
12.11.2 Moderna Description and Business Overview
12.11.3 Moderna Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Moderna Nucleic Acid Vaccine Products Offered
12.11.5 Moderna Recent Development
12.12 Walvax Biotechnology
12.12.1 Walvax Biotechnology Corporation Information
12.12.2 Walvax Biotechnology Description and Business Overview
12.12.3 Walvax Biotechnology Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Walvax Biotechnology Products Offered
12.12.5 Walvax Biotechnology Recent Development
12.13 Fosun Pharma
12.13.1 Fosun Pharma Corporation Information
12.13.2 Fosun Pharma Description and Business Overview
12.13.3 Fosun Pharma Nucleic Acid Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Fosun Pharma Products Offered
12.13.5 Fosun Pharma Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Nucleic Acid Vaccine Industry Trends
13.2 Nucleic Acid Vaccine Market Drivers
13.3 Nucleic Acid Vaccine Market Challenges
13.4 Nucleic Acid Vaccine Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nucleic Acid Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer